Treatment of Childhood Acute Lymphoblastic Leukemia
Public ClinicalTrials.gov record NCT00165087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to reduce the side-effects and discomfort of anti-leukemia therapy, to attain long-term control of the disease and to hopefully eradicate it.
Study identification
- NCT ID
- NCT00165087
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 491 participants
Conditions and interventions
Conditions
Interventions
- asparaginase (E. Coli) Drug
- asparaginase (Erwina) Drug
- dexrazoxane Drug
- doxorubicin Drug
- cranial radiation (once daily fractionation) Procedure
- cranial radiation (twice-daily fractionation) Procedure
- Intrathecal chemotherapy without radiation Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- Up to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 1995
- Primary completion
- Aug 31, 2006
- Completion
- Aug 31, 2006
- Last update posted
- Dec 27, 2007
1996 – 2006
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ochsner Clinic | New Orleans | Louisiana | 70121 | — |
| Maine Medical Center | Lewiston | Maine | 04240 | — |
| Children's Hospital Boston | Boston | Massachusetts | 02115 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Mt. Sinai Medical Center | New York | New York | 10029 | — |
| University of Rochester | Rochester | New York | 14627 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00165087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2007 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00165087 live on ClinicalTrials.gov.